Darktrace PLC

Director's Dealing • Aug 5, 2022

National Storage Mechanism | Additional information

RNS Number : 1343V

Darktrace PLC

05 August 2022

5 August 2022

Darktrace plc

("Darktrace")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Darktrace announces that it has been notified of the following PDMR transactions.

Nicole Eagan, Chief Strategy Officer and AI Officer, has notified Darktrace that on 4 August 2022 she sold 250,538 ordinary shares in Darktrace at an aggregate price of 399.14 pence per share. This sale represents less than 1.8% of Nicole Eagan's total vested and unvested shareholding in Darktrace.

Details of PDMR / person closely associated with them ("PCA")

Name

Nicole Eagan

Reason for the notification

Position / status

Chief Strategy Officer and AI Officer

Initial notification / amendment

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Darktrace plc

LEI

213800PC5S5P9CSNFC89

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument

Identification code

Shares

Dark / GB00BNYK8G86

Nature of the transaction

Sale of shares

Currency

GBP - British Pound

Price(s) and volume(s)

	Price(s)	Volume(s)	Total
	3.99	250,538	£999,997.37
Aggregated	3.991	250,538	£999,997.37

Date of the transaction

4 August 2022

Place of the transaction

London

Contact:

Luk Janssens - Head of Investor Relations, Darktrace

luk.janssens@darktrace.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEAAPSESAAEFA